(People’s Daily Health Client Reporter Gao Ruirui) “The new crown oral drug Azvudine Tablets was officially put into production in Pingdingshan, and the annual output of the preparations can reach 3 billion tablets, which can meet the dosage needs of patients. Prevention and control can also bring great convenience.” Chang Junbiao, the inventor of azvudine and a professor at Henan Normal University, told the People’s Daily Health Client reporter.
On August 2, the launch ceremony of the new crown oral drug Azvudine Tablets of Henan True Biotechnology Co., Ltd. was held in Pingdingshan City, which also means that Azvudine Tablets officially entered the market. production stage.
Workers are operating instruments on the production floor. Screenshot of Pingdingshan Weibo video
“The official production of azvudine tablets for the new crown oral drug in Pingdingshan is good news for patients with new coronary pneumonia.” Chang Junbiao introduced that the new crown The oral drug Azvudine tablet has three major characteristics. First, it has good antiviral effect. It has been proved by a large number of clinical trials that after taking this antiviral drug, it can quickly reduce the load of the new coronavirus; second, the drug is highly targeted and Long-acting, small drug dosage and relatively small side effects; third, drug prices are low.
It is understood that Azvudine Tablets was approved as an anti-HIV (HIV) drug in July last year, and was produced by Beijing Union Pharmaceutical Co., Ltd. entrusted by Real Biology . On July 25, after the State Food and Drug Administration approved the registration application of Azvudine Tablets for the treatment of new coronavirus pneumonia indications with conditions, in order to meet the needs of large-scale production, Real Bio officially started the production of preparations.
“At the beginning of the design of Azvudine, we designed it as an antiviral drug, and carried out special structural modification and optimization. The in vitro activity screening found that in addition to its strong activity against HIV, Azvudine has good antiviral activity against many other RNA viruses, such as HCV (hepatitis C virus), EV71 (enterovirus) and other RNA viruses. 2020 Since the outbreak of the new crown virus at the beginning of the year, we have conducted in vitro and in vivo anti-new coronavirus activity tests on azvudine, and found that the drug also has strong activity against the new crown virus. , and finally obtained the conditional listing of the State Food and Drug Administration. I hope that the new crown oral drug Azvudine Tablets can be put into the market earlier, so that more patients can use the drug as soon as possible.” Chang Junbiao said.
According to reports, in May this year, the real biological Pingdingshan production base has successfully passed the compliance inspection of the drug production quality management standard organized by the Henan Provincial Food and Drug Administration, marking the company’s own The production base of the company can produce and operate medicines in compliance with regulations. The total construction area of the base is 32,000 square meters, and the annual output of preparations in the future can reach 3 billion pieces.
It is reported that Real Bio is a R&D-driven biotechnology company dedicated to the R&D, manufacturing and commercialization of innovative drugs for the treatment of viral, tumor and cerebrovascular diseases. change.